Use of modafinil in spastic cerebral palsy

Journal of Child Neurology

Volumn 17, Issue 3, 2002, Pages 169-172

  Hurst, Daniel L ^a   Lajara Nanson, Walter ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; MODAFINIL; PLACEBO; BENZHYDRYL DERIVATIVE;

ARTICLE; BRAIN STEM; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; GAIT; HUMAN; MALE; MEDICAL ASSESSMENT; MOBILIZATION; NARCOLEPSY; PHYSIOTHERAPIST; PILOT STUDY; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SPASTICITY; TREATMENT OUTCOME; VIDEOTAPE; WALKING SPEED; ADOLESCENT; BODY WEIGHT; CASE REPORT; FOLLOW UP; METHODOLOGY; PHYSIOTHERAPY; PRESCHOOL CHILD; VIDEORECORDING;

ADOLESCENT; BENZHYDRYL COMPOUNDS; BODY WEIGHT; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; GAIT; HUMANS; MALE; PHYSICAL THERAPY MODALITIES; VIDEOTAPE RECORDING;

EID: 0036018865     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380201700303     Document Type: Article

References (29)

1. Epidemiology of Cerebral Palsy in the Year 2000
2. Potentially asphyxiating conditions and spastic cerebral palsy in infants of normal birth weight
3. The changing panorama of cerebral palsy in Sweden: VII. Prevalence and origin in the birth year period 1987-90
4. Cerebral paraplegia and quadriplegia
5. Spasticity
6. A controlled trial of baclofen in children with cerebral palsy
7. Intrathecal baclofen for management of spastic cerebral palsy: Multicenter trial
8. Surgical management of spastic diplegia in cerebral palsy
9. An evaluation of botulinum A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy
10. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy
11. Potential brain neuronal targets for amphetamine-methylphenidate, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat
12. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy
13. Interrater reliability of a Modified Ashworth Scale of muscle spasticity
14. The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: Prevention by local GABA-A receptor blockade
15. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rate
16. Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice
17. Analysis of stimulant locomotor effects of modafinil in various strains of mice and rats
18. Central alpha 1-adrenergic stimulation in relation to the behavior stimulating effects of modafinil; studies with experimental animals
19. Electroencephalographic effect of modafinil, an alpha-1-adrenergic psychostimulant, on the sleep of rhesus monkeys
20. Effects of modafinil-induced wakefulness and glutamine synthetase regulation in the rat brain
21. Effects of a vigilance-enhancing drug, modafinil, on rat brain metabolism: A 2 d cosy 1h-NMR study
22. The effects of modafinil on striatal, pallial and nigral GABA and glutamate release in the conscious rat: Evidence for a preferential inhibition of striato-pallidal GABA transmission
23. Antiparkinsonian and neuroprotective effects of modafinil in the MPTP-treated common marmoset
24. Differential patterns of regional C-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil
25. Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: Comparison with amphetamine
26. The antiparalytic drug modafinil increases glutamate release in the thalamic areas and hypocampus